Hydrofarm Eliminates $109 Million in Debt, Becoming Debt-Free

The eliminated term loan carried approximately $12 million in annual debt service, while the recapitalization introduces shareholder dilution.

Rhea-AI Summary

Hydrofarm Holdings Group (Nasdaq: HYFM) eliminated its $109 million term loan through a recapitalization that issued securities to former lenders. The company retains an immaterial amount of other debt at a foreign subsidiary. Former lenders received $27.5 million of convertible preferred stock, convertible at $1.00 per common share, and warrants for 27.5 million common shares at $0.78 each.

A registered direct offering and concurrent private placement raised approximately $8.3 million in gross proceeds. Following the offering and preferred-stock conversion, approximately 41.8 million common shares will be outstanding. Hydrofarm intends to seek shareholder approval for the lenders’ preferred conversion and warrant exercise. The company believes its pro-forma equity exceeds Nasdaq’s $2.5 million minimum, but Nasdaq has not confirmed restored compliance. Its previously disclosed $1 minimum bid-price compliance issue also remains unresolved.

6 points · 2 major

MixediHow this balance works

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

How the balance worksHow Sentiment works

2 major · 6 points

Hollow bars mark forward-looking points. How the balance works

Positive

• Major point$109 million term loan eliminated; the loan carried approximately $12 million in annual debt service. 34× market cap
• Major pointApproximately $8.3 million in gross proceeds raised through a registered direct offering and concurrent private placement. 2.6× market cap
• Moderate pointPro-forma stockholders’ equity exceeds $2.5 million, Hydrofarm believes, following the recapitalization and offering.
• Minor pointCosts reduced and productivity improved within the organization.
• Minor point. Forward-looking: it has not happened yet and may not happen.Direct commercial sales expansion is a company priority, including selling cultivation products directly to commercial cannabis growers.
• Minor point. Forward-looking: it has not happened yet and may not happen.Growth priorities include organic brands, international expansion, ecommerce and scaling logistics services.

Negative

• Major point$27.5 million in convertible preferred stock issued to former lenders converts at $1.00 per common share. 8.5× market cap
• Major pointCommon stock and warrants issued in the offering add dilution; approximately 41.8 million common shares follow preferred conversion.
• Moderate pointNasdaq compliance remains unconfirmed for the $2.5 million equity requirement and $1 minimum closing bid-price requirement.
• Minor point. Forward-looking: it has not happened yet and may not happen.27.5 million lender warrants exercisable at $0.78 per common share create potential additional dilution.
• Minor pointShareholder approval remains to be sought for lenders’ preferred-stock conversion and warrant exercise.
• Minor pointImmaterial other debt remains, comprising a foreign subsidiary’s revolving line of credit and mortgage.

News Explained

Resale registration addresses later sales of these securities; it does not replace the shareholder approval needed for lender conversion and warrant exercise.

The recapitalization is complete, and Hydrofarm says it removes approximately $12 million in annual debt service tied to the former term loan.

Hydrofarm also says it has agreed to file registration statements covering resale of securities issued to former lenders and in the private placement.

Argus 15 min delay 49 alerts

-16.51% vs previous close $0.5574 last price 91.4x rel. volume Open Argus

Details

Market move: HYFM -16.51% vs previous close. Term loan recapitalization

+20.2% Peak Tracked

-28.5% Trough Tracked

$0.52 – $0.87 Day Range

$2.69M Mkt Cap at Last Price

On Nov 3, the day this news came out, the latest delayed price for HYFM is 16.51% below the previous close. Argus tracked a peak move of +20.2% during the session. Argus tracked a trough of -28.5% from its starting point during tracking. Our momentum scanner has recorded 49 alerts for this stock so far that day. The latest delayed price is $0.56. Relative volume is exceptionally heavy at 91.4x the stock’s average daily volume.

Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.

Key Figures

Term loan eliminated: $109 million Former annual debt service: Approximately $12 million Preferred stock consideration: $27.5 million; convertible at $1.00 per share +4 more

Term loan eliminated

$109 million

Debt eliminated in the recapitalization

Former annual debt service

Approximately $12 million

Annual debt service before the recapitalization

Preferred stock consideration

$27.5 million; convertible at $1.00 per share

Series 1 preferred stock issued to former term loan lenders

Lender warrants

27.5 million shares at $0.78 per share

Warrants issued to former term loan lenders

Offering gross proceeds

Approximately $8.3 million

Registered direct offering and concurrent private placement

Pro forma common shares outstanding

Approximately 41.8 million shares

Following the offering and conversion of preferred stock

Nasdaq minimum stockholders’ equity

$2.5 million

Equity Rule minimum; the company said pro forma equity exceeds it

Historical Context

2 past events · Latest: Oct 28

2 events

1. Oct 28

   Offering closed

   24h Move

   +4.6%

   Closed $8.3 million financing alongside extinguishment of the $109 million term loan.

2. Oct 27

   Recapitalization priced

   24h Move

   -6.6%

   Priced an $8.3 million offering with lender exchange terms to satisfy the $109 million loan.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

registered direct offering, private placement, convertible preferred stock, warrants, +1 more

5 terms

registered direct offering financial

"sold common stock and warrants to investors in a registered direct offering"

A registered direct offering is a way for a company to sell new shares of its stock directly to select investors with regulatory approval. This method allows the company to raise funds quickly and efficiently without needing a public auction, similar to offering exclusive access to a limited number of buyers. For investors, it often provides an opportunity to purchase shares at a favorable price, while giving the company immediate access to capital.

private placement financial

"a registered direct offering and concurrent private placement"

A private placement is a sale of securities directly to a selected group of investors, typically institutions or accredited investors, instead of through a public offering. It lets a company raise money faster and with fewer regulatory steps; for existing shareholders it matters because the newly issued shares, often sold at a discount, increase the share count and can dilute their ownership.

convertible preferred stock financial

"newly created class of Series 1 Non-Voting Convertible Preferred Stock"

Convertible preferred stock is a special class of company shares that pays priority, usually fixed, payments to holders and can be exchanged later for a set number of common shares. It matters to investors because it combines steady income and added protection with the chance to share in a company’s upside; think of it as a hybrid between a bond that pays regularly and an option to convert into growth-oriented stock, where the conversion rules influence both potential gains and how much common shareholders’ ownership may be reduced.

warrants financial

"and warrants to purchase 27.5 million shares of common stock"

Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.

View in glossary

form 8-k regulatory

"Current Reports on Form 8-K filed with the Securities and Exchange Commission"

A Form 8-K is a report that companies file with the government to share important news quickly, such as changes in leadership, major business deals, or financial updates. It matters because it helps investors stay informed about significant events that could affect the company's value or stock price.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SHOEMAKERSVILLE, Pa., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Hydrofarm Holdings Group, Inc. (“Hydrofarm” or the “Company”) (Nasdaq: HYFM), a leading independent manufacturer and distributor of branded supplies and equipment for controlled environment agriculture (“CEA”), today provides additional detail on its debt elimination⁽ⁱ⁾.

The Recapitalization:

Prior to these actions, the Company had a $109 million Term Loan, with approximately $12 million of annual debt service. In the recapitalization, the Term Loan was eliminated, and the former Term Loan Lenders received $27.5 million of a newly created class of Series 1 Non-Voting Convertible Preferred Stock, convertible to common stock at $1.00 per share, and warrants to purchase 27.5 million shares of common stock at an exercise price of $0.78 per share. In addition, Hydrofarm sold common stock and warrants to investors in a registered direct offering and concurrent private placement (the “Offering”), raising approximately $8.3 million in gross proceeds. Officers and directors of the Company participated in the Offering on the same terms as other investors. Following the Offering and conversion of the Preferred Stock, the Company will have approximately 41.8 million common shares outstanding.

Hydrofarm now has no outstanding debt⁽ⁱ⁾ and enhanced liquidity, providing the Company with flexibility to support strategic initiatives and capitalize on market opportunities.

“This is a monumental time for Hydrofarm,” said Bill Toler, Chairman and Chief Executive Officer. “With no debt on our balance sheet, we enter our 50th year in 2027 independent and built to scale. We are also excited about the opportunity to sell our cultivation products directly to commercial cannabis growers, removing a long-standing market access barrier and creating a more robust channel for our products.”

Strategic Priorities:

Hydrofarm remains committed to drive high-quality revenue streams, improve profit margins and strengthen its financial position. The Company’s proprietary and partner brands span the CEA, gardening and agriculture markets. The Company has reduced costs and improved productivity within the organization. Now with the recapitalization complete, Hydrofarm is focused on sustainable growth through commercial direct offerings, organic brands, international expansion, ecommerce, and logistics services.

“The recapitalization reflects the commitment of our organization, former lenders, and investors to build a stronger financial foundation to scale the Hydrofarm platform,” said Eric Ceresnie, Senior Vice President of Corporate Development and International Markets. “We are a lean and focused organization with a capital structure to support growth. We are excited about expanding the direct commercial sales channel, scaling our logistics services platform, and pursuing additional growth opportunities. I’m proud of the resilience of our organization, investors, customers, and vendor partners have shown to get us here. Now we can execute and build.”

Nasdaq Listing Compliance and Other Information:

As previously disclosed, the Company was not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires a minimum of $2.5 million in stockholders’ equity (the “Equity Rule”). Giving effect to the recapitalization and offering, the Company believes that the Company’s pro-forma stockholders’ equity exceeds the $2.5 million minimum, and that the Company has regained compliance with the Equity Rule. As previously disclosed, the Company was also not in compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum closing bid price of $1 per share (the “Bid Price Rule”). The Company remains subject to Nasdaq’s continued monitoring of its compliance with the Equity Rule and the other Nasdaq Listing Rules, including the Bid Price Rule, and there can be no assurance that Nasdaq will find that the Company has regained compliance with the Equity Rule or the Bid Price Rule, or that the Company will remain in compliance with the Nasdaq Listing Rules.

Additional information regarding the recapitalization is set forth in the Company’s Current Reports on Form 8-K filed with the Securities and Exchange Commission (the “SEC”) on October 27, 2026, and in the Company’s press releases dated October 27 and October 28, 2026.

The registered direct offering was made pursuant to an effective shelf registration statement on Form S-3 previously filed with the SEC and declared effective on December 10, 2025, the base prospectus dated December 10, 2025 thereunder and a prospectus supplement to the base prospectus filed on October 29, 2026 with the SEC. Copies of the final prospectus may be obtained from ThinkEquity, 17 State Street, 41st Floor, New York, New York 10004. The final prospectus was filed with the SEC and is available on the SEC’s website located at http://www.sec.gov.

The securities sold in the concurrent private placement, and the Series 1 Non-Voting Convertible Preferred Stock and warrants issued to the former Term Loan lenders, have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), or state securities laws, and may not be offered or sold in the United States absent registration with the SEC or an applicable exemption from such registration requirements. Hydrofarm has agreed to file registration statements with the SEC covering the resale of those securities and the shares of common stock issuable upon their exercise or conversion. Any such resale will be made only by means of a prospectus.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of any securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. This press release is not a solicitation of a proxy. Stockholders are urged to read the Company’s proxy statement, when it becomes available, because it will contain important information.

Hydrofarm intends to file a proxy statement seeking among other things, shareholder approval of the conversion of the Series 1 Non-Voting Convertible Preferred Stock and the exercise of the warrants issued to the former Term Loan lenders, and to hold a shareholder meeting as promptly as practicable. The Company also intends to file registration statements covering the resale of securities issued in the private placement and to the former Term Loan lenders.

(i) Hydrofarm maintains an immaterial amount of ‘Other debt’ comprised of a foreign subsidiary’s revolving line of credit and mortgage.

About Hydrofarm Holdings Group, Inc.

Hydrofarm is a leading independent manufacturer and distributor of supplies and equipment for controlled environment agriculture, including plant nutrition, growing media, horticultural lighting and climate control solutions, spanning a portfolio of proprietary and select partner brands. The Company manufactures its proprietary plant nutrition and growing media brands at its manufacturing center of excellence in Eugene, Oregon, and, through its logistics services platform, provides third-party warehousing, fulfillment and distribution services across a wide range of industries. For nearly 50 years, Hydrofarm has helped growers make growing easier and more productive. The Company’s mission is to empower growers, farmers and cultivators with products that enable greater quality, efficiency, consistency and speed.

www.Hydrofarm.com

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by words such as “believe,” “expect,” “intend,” “anticipate,” “plan,” “will,” “project,” “potential” and similar expressions. They include, among others, statements regarding: the receipt of stockholder approval for the conversion of the Series 1 Non-Voting Convertible Preferred Stock and the exercise of the warrants issued to the former Term Loan lenders, and the timing of the related proxy statement and stockholder meeting; whether any warrants will be exercised and the amount of any additional proceeds therefrom; the timing of the filing and effectiveness of resale registration statements, if at all; the Company’s pro forma capitalization and stockholders’ equity; the Company’s belief that it has regained compliance with the Equity Rule and its ability to regain or maintain compliance with Nasdaq continued listing requirements, including the Bid Price Rule; the Company’s competitive position and the strength of its brand portfolio; the expected benefits of the consolidation of manufacturing into the Company’s Eugene, Oregon manufacturing center of excellence, including productivity and cost improvements; the ability to generate future growth, revenue and commercial opportunities from direct-to-cannabis grower sales following the elimination of restrictions under the Term Loan; the objectives, scope and anticipated results of Project Agility, including growth of the Company’s logistics services platform; the timing of the Company’s third quarter 2026 results; and the Company’s future financial performance, margins, liquidity and capital allocation plans.

These statements are based on management’s current expectations and assumptions. They are subject to risks and uncertainties that could cause actual results to differ materially, including: the risk that stockholders do not approve the conversion of the Series 1 Non-Voting Convertible Preferred Stock or the exercise of the warrants issued to the former Term Loan lenders, or that approval is delayed; the risk that the Company does not regain or maintain compliance with Nasdaq continued listing requirements, including the Equity and Bid Price Rules, and the risk that its securities could be delisted; the potential dilution to existing stockholders from the issuance of common stock, pre-funded warrants and common warrants to investors in the registered direct offering and concurrent private placement, and the issuance of the Series 1 Non-Voting Convertible Preferred Stock and common warrants to the former Term Loan lenders, and from any later conversion or exercise thereof; the impact on the market price of the common stock of future sales of shares; the risk that the Company cannot file or obtain effectiveness of the required resale registration statements; the final accounting treatment of the Series 1 Non-Voting Convertible Preferred Stock and the warrants issued in the transactions; the Company’s history of operating losses; demand conditions in the CEA and hydroponics markets; the Company’s ability to execute on Project Agility and its other growth initiatives including direct-to-cannabis grower sales; and the other factors described under “Risk Factors” in the Company’s Annual Report on Form 10-K and subsequent periodic reports filed with the SEC. Pro forma figures are unaudited and illustrative and are not necessarily indicative of the Company’s actual financial position. Forward-looking statements speak only as of the date of this release, and the Company undertakes no obligation to update them except as required by law.

Contact: ir@hydrofarm.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Is Hydrofarm HYFM completely debt-free after its recapitalization?

Hydrofarm eliminated its $109 million term loan, but retains an immaterial amount of other debt. That remaining debt consists of a foreign subsidiary’s revolving line of credit and mortgage. The eliminated term loan carried approximately $12 million in annual debt service.

What securities did Hydrofarm issue to eliminate its term loan?

Former term-loan lenders received $27.5 million of Series 1 Non-Voting Convertible Preferred Stock, convertible into common stock at $1.00 per share, plus warrants to purchase 27.5 million common shares at $0.78 per share. Hydrofarm intends to seek shareholder approval for the preferred-stock conversion and warrant exercise.

How can Hydrofarm shareholders review the proposed approval of lender securities?

Shareholders should read Hydrofarm’s proxy statement when it becomes available for information about the proposed approvals. The company intends to file the proxy statement and hold a shareholder meeting as promptly as practicable to seek, among other things, approval of the lenders’ preferred-stock conversion and warrant exercise.